Price$92.84-0.77 (-0.82%)
01:30 PM07:45 PM
News · 26 weeks31+175%
2025-12-282026-06-21
Mix2090d
- Insider13(65%)
- SEC Filings3(15%)
- Other2(10%)
- Dividends1(5%)
- Leadership1(5%)
Latest news
25 items- INSIDERCAO Crennen Lyndsey Elizabeth sold $39,560 worth of shares (442 units at $89.50), exercised 726 shares at a strike of $95.10 and was granted 263 shares, increasing direct ownership by 37% to 2,020 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSVP Operations Archbold Brian David exercised 3,324 shares at a strike of $95.10, was granted 1,859 shares and sold $225,187 worth of shares (2,516 units at $89.50), increasing direct ownership by 72% to 6,377 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERCFO Sakys John exercised 3,792 shares at a strike of $95.10, was granted 2,282 shares and sold $253,022 worth of shares (2,827 units at $89.50) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 19,785 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSVP Operations Archbold Brian David sold $116,558 worth of shares (1,151 units at $101.27), decreasing direct ownership by 24% to 3,710 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERCAO Crennen Lyndsey Elizabeth sold $11,950 worth of shares (118 units at $101.27), decreasing direct ownership by 7% to 1,473 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERCFO Sakys John sold $123,850 worth of shares (1,223 units at $101.27), decreasing direct ownership by 7% to 16,538 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERNew insider Crennen Lyndsey Elizabeth claimed ownership of 1,863 shares (SEC Form 3)3 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSVP Operations Archbold Brian David exercised 2,454 shares at a strike of $104.08, increasing direct ownership by 102% to 4,861 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERCFO Sakys John exercised 2,717 shares at a strike of $104.08, increasing direct ownership by 18% to 17,761 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- SECMesa Laboratories Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- SECSEC Form S-8 filed by Mesa Laboratories Inc.S-8 - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- SECMesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- PRMesa Labs Announces Fourth Quarter and Fiscal Year 2026 ResultsLAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter ("4Q26") and fiscal year ("FY26") ended March 31, 2026 (amounts in thousands). 4Q26 Financial Summary – (comparisons are versus the same prior year period) Revenues increased 2.6%Non-GAAP organic and core organic revenues1 growth was 2.6% and (0.6)%, respectivelyOperating income increased 87% to $2,748Non-GAAP adjusted operating income ("AOI") excluding unusual items2 increased 49.2% and was 28.7% as a percentag
- INSIDERAmendment: SEC Form 4 filed by President and CEO Kadia Siddhartha4/A - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- PRMesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately 6:00 A.M. Eastern Time (ET) on Wednesday, May 27, 2026. About Mesa LaboratoriesMesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. Mesa Laboratories C
- INSIDERSEC Form 4 filed by President and CEO Kadia Siddhartha4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERSEC Form 3 filed by new insider Kadia Siddhartha3 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- PRMESA LABS DECLARES QUARTERLY DIVIDENDLAKEWOOD, Colo., April 02, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase pa
- INSIDERSEC Form 4 filed by Owens Gary M4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Mesa Laboratories Inc.SCHEDULE 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)
- SECMesa Laboratories Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
- INSIDERDirector Ladiwala Shiraz Shabanali bought $252,805 worth of shares (3,500 units at $72.23), increasing direct ownership by 70% to 8,523 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Capone Mark Christopher bought $99,331 worth of shares (1,301 units at $76.35), increasing direct ownership by 61% to 3,429 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- INSIDERDirector Tripeny R Tony bought $99,940 worth of shares (1,315 units at $76.00), increasing direct ownership by 32% to 5,398 units (SEC Form 4)4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)
- SECMesa Laboratories Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)
MLAB FAQ
7 questionsWhat does Mesa Laboratories Inc. do?
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment...Where does MLAB stock trade?
Mesa Laboratories Inc. (MLAB) is listed on NASDAQ.What sector and industry is MLAB in?
Mesa Laboratories Inc. operates in the Industrials sector, Industrial Machinery/Components industry.Does MLAB pay a dividend?
MLAB's most recent ex-dividend date was 2026-05-29 with a cash dividend of $0.16 per share. No future ex-date is on file yet.What are analysts saying about MLAB?
Mesa Laboratories Inc. has had 3 recent analyst actions on file. The most recent action was from Wells Fargo: Equal Weight on 2025-08-07.What companies are similar to MLAB?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), ETN (Eaton Corporation PLC). Compare MLAB side-by-side with any of them on Quantisnow.How can I track MLAB on Quantisnow?
Quantisnow aggregates Mesa Laboratories Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MLAB to receive live email and push alerts on every new disclosure.